Pseudothophus form of calcium pyrophosphate deposition disease: Features of diagnosis and course of the disease (description of a clinical case)
https://doi.org/10.47360/1995-4484-2025-407-414
Abstract
Calcium pyrophosphate deposition disease (CPPD) is a disease that occurs under the guise of various diseases and is characterized by a variety of clinical forms. One of the most rare and diagnostically difficult variants is chronic arthritis with the formation of periarticular deposits of calcium pyrophosphate crystals, imitating gouty tophi. The article presents a clinical case and analysis of the differential diagnosis of a patient with a pseudo-tophaceous form of CPPD.
About the Authors
M. V. Shalygina
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Mariya V. Shalygina
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
none
M. D. Suprun
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Marina D. Suprun
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
none
M. S. Eliseev
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Maxim S. Eliseev
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
none
L. A. Semyonova
V.A. Nasonova Research Institute of Rheumatology; Central Tuberculosis Research Institute
Russian Federation
Competing Interests:
Russian Federation
Lyudmila A. Semyonova
115522, Moscow, Kashirskoye Highway, 34A; 107564, Moscow, Yauszkaya alley, 2
Competing Interests:
none
References
1. Barskova VG, Ilyina AE, Semenova LA, Radenska-Lopovok SG, Osipyants MA, Smirnov AV, et al. Pyrophosphate arthropathy is a rheumatological iceberg syndrome: Time to reassess its importance in joint diseases. Modern Rheumatology Journal. 2010;4(2):5-11 (In Russ.). doi: 10.14412/1996-7012-2010-595
2. Pineda C, Sandoval H, Pérez-Neri I, Soto-Fajardo C, Carranza-Enríquez F. Calcium pyrophosphate deposition disease: Historical overview and potential gaps. Front Med (Lausanne). 2024;11:1380135. doi: 10.3389/fmed.2024.1380135
3. McCarty DJ. Crystal-induced inflammation of the joints. Annu Rev Med. 1970;21:357-366. doi: 10.1146/annurev.me.21.020170.002041
4. Zhang W, Doherty M, Bardin T, Barskova V, Guerne PA, Jansen TL, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: Terminology and diagnosis. Ann Rheum Dis. 2011;70(4):563-570. doi: 10.1136/ard.2010.139105
5. Sadiq M, Nayak M, Farheen A, Digge V. An unusual case of huge tophaceous pseudogout mimicking as a tumor-like lesion around the ankle joint: A case report and literature review. Case Rep Orthop. 2019;2019:9617184. doi: 10.1155/2019/9617184
6. Cheremushkina EV, Eliseev MS, Zhelyabina OV. Cervical vertebrae affection in calcium pyrophosphate crystal deposition disease (description of a clinical case). Modern Rheumatology Journal. 2021;15(5):85-88 (In Russ.). doi: 10.14412/1996-7012-2021-5-85-88
7. Hollander JL, Jessar RA, McCarty DJ. Synovianalysis: An aid in arthritis diagnosis. Bull Rheum Dis. 1961;12:263-264.
8. Abhishek A, Tedeschi SK, Pascart T, Latourte A, Dalbeth N, Neogi T, et al. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease. Arthritis Rheumatol. 2023;75(10):1703-1713. doi: 10.1002/art.42619
9. Eliseev MS, Zhelyabina OV, Chikina MN. Age-related features of calcium pyrophosphate deposition disease. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2019;57(6):651-656 (In Russ.). doi: 10.14412/1995-4484-2019-651-656
10. Reijnierse M, Schwabl C, Klauser A. Imaging of crystal disorders: Calcium pyrophosphate dihydrate crystal deposition disease, calcium hydroxyapatite crystal deposition disease and gout pathophysiology, imaging, and diagnosis. Radiol Clin North Am. 2022;60(4):641-656. doi: 10.1016/j.rcl.2022.03.007
11. Yamakawa K, Iwasaki H, Ohjimi Y, Kikuchi M, Iwashita A, Isayama T, et al. Tumoral calcium pyrophosphate dihydrate crystal deposition disease. A clinicopathologic analysis of five cases. Pathol Res Pract. 2001;197(7):499-506. doi: 10.1078/0344-0338-00118
12. Boyce AM, Lee AE, Roszko KL, Gafni RI. Hyperphosphatemic tumoral calcinosis: Pathogenesis, clinical presentation, and challenges in management. Front Endocrinol (Lausanne). 2020;11:293. doi: 10.3389/fendo.2020.00293
13. Raupov RK, Kostik MM, Avramenko VV, Krasnogorskaya ОL, Chikova IА, Masalova VV, et al. Pigmented villonodular synovitis (tenosynovial giant cell tumor) in rheumatologists’ practice: Literature review and own patient management experience. Pediatria n.a. G.N. Speransky. 2019;98(3):112-119 (In Russ.). doi: 10.24110/0031-403X-2019-98-3-112-119
14. Denisov LN, Nesterenko VA, Smirnov AV. Pigmented villonodular synovitis: Literature review and case report. Modern Rheumatology Journal. 2022;16(3):91-95 (In Russ.). doi: 10.14412/1996-7012-2022-3-91-95
15. Елисеев МС. Алгоритм диагностики и лечения подагры. РМЖ. 2015;7:410. [Eliseev MS. Algorithm for diagnostics and treatment of gout. RMJ. 2015;7:410 (In Russ.)].
16. Nakamura O, Kaji Y, Yamagami Y, Yamaguchi K, Nishimura H, Fukuoka N, et al. A rare case of tumoral calcium pyrophosphate dihydrate crystal deposition disease of the wrist joint. Case Rep Orthop. 2015;2015:313291. doi: 10.1155/2015/313291
17. Rothschild BM, Round MJ. Subcutaneous crystal deposition in pseudogout. JAMA. 1980;244(18):2079-2080.
18. Allen EA, Ali SZ, Erozan YS. Tumoral calcium pyrophosphate dihydrate deposition disease: Cytopathologic findings on fine-needle aspiration. Diagn Cytopathol. 1996;15(4):349-351. doi: 10.1002/(SICI)1097-0339(199611)15:4<349::AID-DC20>3.0.CO;2-N
19. Pakzad K, Yang YJ, Ambrose JL, Landas SK. Diagnosis of calcium pyrophosphate dihydrate deposition disease by fine needle aspiration biopsy: A case report. Acta Cytol. 2002;46(1):46-49. doi: 10.1159/000326715
20. Biankin S, Jaworski R, Mawad S. Tumoural calcium pyrophosphate dihydrate crystal deposition disease presenting clinically as a malignant soft tissue mass diagnosed on fine needle aspiration biopsy. Pathology. 2002;34(4):336-338. doi: 10.1080/003130202760120490
21. Naqvi AH, Abraham JL, Kellman RM, Khurana KK. Calcium pyrophosphate dihydrate deposition disease (CPPD)/pseudogout of the temporomandibular joint – FNA findings and microanalysis. Cytojournal. 2008;5:8. doi: 10.1186/1742-6413-5-8
22. Tantillo TJ, Chang K, Tan S, Sirotnikov S, Goodman HJ. An unusual pathologic ulna fracture induced by intraosseous tumoral calcium pyrophosphate dihydrate crystal deposition disease. J Hand Surg Glob Online. 2022;4(4):233-238. doi: 10.1016/j.jhsg.2022.04.010
23. Chakravorty A, Murambi RT, Cherukuri RKV. Intradural calcium pyrophosphate dihydrate deposition disease: Case report. J Neurosurg Spine. 2021;34(5):804-807. doi: 10.3171/2020.9.SPINE201010
24. Linthoudt DV. Tophus digital de cristaux de pyrophosphate de calcium. Rev Med Suisse. 2009;5(205):1223-1227. doi: 10.53738/REVMED.2009.5.205.1223
25. Akella DS, Ghezavati A, Siddiqui HA, Erbele ID. Middle eartophi: A case series of two unusual lesions and a report of facial weakness and review of the literature. Otol Neurotol. 2024;45(4):e333-e336. doi: 10.1097/MAO.0000000000004159
26. Pascart T, Filippou G, Lioté F, Sirotti S, Jauffret C, Abhishek A. Calcium pyrophosphate deposition disease. Lancet Rheumatol. 2024;6(11):e791-e804. doi: 10.1016/S2665-9913(24)00122-X
27. Barskova VG. Diagnostics of calcium pyrophosphate crystal deposition disease (pyrophosphate arthropathy). RMJ. 2012;7:350 (In Russ.)
28. Eliseev MS, Novikova AM, Zhelyabina OV. Chondrocalcinosis: An early sign of primary hyperparathyroidism. Doctor.Ru. 2020;19(11):52-55 (In Russ.). doi: 10.31550/1727-2378-2020-19-11-52-55
Review
For citations:
Shalygina M.V., Suprun M.D., Eliseev M.S., Semyonova L.A. Pseudothophus form of calcium pyrophosphate deposition disease: Features of diagnosis and course of the disease (description of a clinical case). Rheumatology Science and Practice. 2025;63(4):407-414. (In Russ.) https://doi.org/10.47360/1995-4484-2025-407-414
Views:
50
Email this article 